Bionano Genomics, Inc.
Cash Flow Statement
| Line Item | FY2017 |
|---|---|
| Operating Activities | |
| Net Income | $-23.4M |
| Depreciation & Amortization | $1.5M |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $382.8K |
| Net Cash from Operating Activities | $-20.8M |
| Investing Activities | |
| Capital Expenditures | $1.0M |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-1.0M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $17.6M |
| Net Change in Cash | $-4.2M |
| Free Cash Flow | $-21.8M |